Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticle
Open Access

Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers

NORIKO NAKAMURA, PAUL ROGERS, RÉMELLE EGGERSON, STEVEN R. POST and RODNEY DAVIS
Cancer Genomics & Proteomics January 2023, 20 (1) 1-8; DOI: https://doi.org/10.21873/cgp.20359
NORIKO NAKAMURA
1Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: noriko.nakamura{at}fda.hhs.gov
PAUL ROGERS
2Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RÉMELLE EGGERSON
3Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEVEN R. POST
3Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RODNEY DAVIS
4Department of Urology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Relative transcript levels of BMP7, BMPR2, NFKB1, IL7R, NCF, CXCL13, NOS2, CCL2, NCAM1, ITGA4, ESRRG, hsa-miR329/miR-92, and hsa-miR-329/miR-26b, in the PCa tissues Data are expressed as mean fold change ± standard error of the mean (N=18/group). *p≤0.05 compared to clean tissues.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Power versus standard deviation for a one-unit mean difference in a paired t-test (A) or a Wilcoxon signed rank test (B) with a sample size of 18, at a 0.05 level of significance.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
  • Table V.
  • Table VI.
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 20 (1)
Cancer Genomics & Proteomics
Vol. 20, Issue 1
January-February 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers
NORIKO NAKAMURA, PAUL ROGERS, RÉMELLE EGGERSON, STEVEN R. POST, RODNEY DAVIS
Cancer Genomics & Proteomics Jan 2023, 20 (1) 1-8; DOI: 10.21873/cgp.20359

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers
NORIKO NAKAMURA, PAUL ROGERS, RÉMELLE EGGERSON, STEVEN R. POST, RODNEY DAVIS
Cancer Genomics & Proteomics Jan 2023, 20 (1) 1-8; DOI: 10.21873/cgp.20359
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK
  • Google Scholar

More in this TOC Section

  • Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
  • Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
  • Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
Show more Article

Keywords

  • Humans
  • chronic prostatitis
  • genes
  • prostatitis
  • rats
  • prostate cancer tissues
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire